Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Hematopoietic Stem Cell Transplant and Brain Volume Changes in Adults With Sickle Cell Disease.
Journal: Neurology
Published: May 14, 2026
Nonmyeloablative Pentostatin-Cyclophosphamide Preconditioning Improves Rates of Engraftment in Adults Undergoing Haploidentical HCT for Sickle Cell Disease.
Journal: medRxiv : the preprint server for health sciences
Published: September 15, 2025
Malaria Screening and Treatment in Hematopoietic Cell Transplant Donors and Sickle Cell Disease Candidates/Recipients: A Case Series Using Malaria Polymerase Chain Reaction Testing and a Literature Review.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: September 11, 2025
Nonmyeloablative pentostatin-cyclophosphamide preconditioning improves rates of engraftment in adults undergoing haploidentical HCT for sickle cell disease.
Journal: PloS one
Published: September 11, 2025
Usefulness and Limitations of Polymerase Chain Reaction (PCR) for the Diagnosis and Management of Toxoplasmosis Following Allogeneic Hematopoietic Cell Transplant: Single-center Experience With 31 Patients Over 16 Years.
Journal: Open forum infectious diseases
Published: March 27, 2025
Recipient Cells Are the Source of Hematologic Malignancies After Graft Failure and Mixed Chimerism in Adults with SCD.
Journal: medRxiv : the preprint server for health sciences
Published: January 27, 2025
Reply to Holbert and Fraidenburg: Not to Be Forgotten. Pulmonary Vascular Effects of Nonmyeloablative Hematopoietic Cell Transplant for Sickle Cell Disease.
Journal: Annals of the American Thoracic Society
Published: January 21, 2025
Recipient Cells Are the Source of Hematologic Malignancies After Graft Failure and Mixed Chimerism in Adults With SCD.
Journal: American journal of hematology
Published: January 03, 2025
Pulmonary Function after Nonmyeloablative Hematopoietic Cell Transplant for Sickle Cell Disease.
Journal: Annals of the American Thoracic Society
Published: August 27, 2024
Lipid Levels Increase to the Normal Range After Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease.
Journal: Transplantation and cellular therapy
Published: August 05, 2024
Kidney function after nonmyeloablative hematopoietic cell transplant for sickle cell disease.
Journal: Bone marrow transplantation
Published: July 21, 2024
Last Updated: 09/26/2026